Randomized, multicenter, phase III trial to compare S-1 plus docetaxel (DS) with S-1 plus cisplatin (SP) in gastric cancer patients with stage III (POST trial).

Authors

null

Choong-kun Lee

Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea

Choong-kun Lee , Minkyu Jung , Seok Yun Kang , Bong-Seog Kim , Ki Hyang Kim , Kyung Hee Lee , Moon Hee Lee , Dong Bok Shin , Dae Young Zang , Ji Yeong Ahn , Hyoung-Il Kim , Woo Jin Hyung , Sung Hoon Noh , Hyo Song Kim , Hyun Cheol Chung , Sun Young Rha

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2014 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal (Noncolorectal) Cancer

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Esophageal or Gastric Cancer

Clinical Trial Registration Number

NCT01283217

Citation

J Clin Oncol 32:5s, 2014 (suppl; abstr 4069)

DOI

10.1200/jco.2014.32.15_suppl.4069

Abstract #

4069

Poster Bd #

156

Abstract Disclosures